Home / Markets / KLRA / Balance Sheet ← All companies K Kailera Therapeutics, Inc. KLRA - CIK 0002096997
Overview Market Cap Revenue Net Income Income Statement Balance Sheet Cash Flow SEC Filings KLRA balance sheet (quarterly) The table below shows Kailera Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item Q1 2026 Cash & equivalents $111.83M Short-term investments $407.35M Receivables - Inventory - Total current assets $530.32M Property, plant & equipment $1.85M Goodwill - Total assets $624.76M Accounts payable $7.09M Total current liabilities $54.84M Long-term debt - Total liabilities $64.48M
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings .